Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (HKG:6990)
Hong Kong · Delayed Price · Currency is HKD
369.80
+21.80 (6.26%)
Last updated: Mar 5, 2026, 3:59 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 1.93B | 1.54B | 803.93M | 32.32M |
| 25.48% | 91.62% | 2387.26% | - |
| 1.93B | 1.54B | 803.93M | 32.32M |
| 25.48% | 91.62% | 2387.26% | - |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|
| Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
|---|
| 92.65M | 7.54M | 56.49M | 20.39M |
| 1128.18% | -86.64% | 177.11% | - |
The United States of America | 1.84B | 1.53B | 730.04M | - |
The United States of America Growth | 20.43% | 109.33% | - | - |
| - | 4.73M | 17.41M | 11.94M |
| - | -72.85% | 45.83% | - |
| 1.93B | 1.54B | 803.93M | 32.32M |
| 25.48% | 91.62% | 2387.26% | - |
Source: S&P Global Market Intelligence.